Media

Media

Recent News

  • Avivagen Announces Proposed Extension of Warrants

    Ottawa, ON / Business Wire/ October 15, 2019/ – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, today announced that it will be requesting approval from the TSX Venture …Read More

  • Avivagen Announces First Order for OxC-beta™ Livestock in Taiwan

    Ottawa, ON / BusinessWire/ October 8, 2019/ – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, is pleased to announce that it has received its first order for OxC-beta™ …Read More

  • Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2019

    Ottawa, ON /Business Wire/ September 9, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™  technology, announces its unaudited financial results for the third quarter of 2019. For the three-month period ended July 31, 2019, the Corporation reported revenues of $12,484, a decrease …Read More

  • Demand for OxC-beta™ Livestock Continues to Grow as Avivagen Secures Another Order in Asia-Pacific

    Ottawa, ON /Business Wire/ August 26, 2019 / Avivagen Inc. (TSXV:VIV) (“Avivagen”) has secured a new order for two metric tons of OxC-betaTM Livestock (“OxC-beta”) from UNAHCO, its partner in the Philippines. The new order marks the third multi-metric ton order of OxC-betaTM  Livestock by UNAHCO in the past 10 months, helping the company meet …Read More

  • Avivagen Announces Approval for OxC-beta™ Livestock (“OxC-beta”) in Mexico

    Avivagen Inc. (TSXV:VIV) is pleased to announce that it has received approval for OxC-beta™ Livestock (“OxC-beta”) in Mexico.

View All News Releases

Media Coverage

  • VICTAM Asia

    Avivagen CEO Interviewed at VICTAM Asia 2018 Conference

    Avivagen recently debuted at the VICTAM ASIA 2018 Conference in Bangkok, Thailand.

  • CEO Kym Anthony Interviewed by Uptick

    CEO Kym Anthony was interviewed by the penny stock news and trends podcast, Uptick Newswire.

    I think if people keep their eyes on the size of the prize, [they’ll see] the livestock market is in the billions of dollars; our share of that would be in the hundreds of millions if we roll out successfully. The human market is untouched. The companion animal market is also big. We’ve spent years proving it works; everyone agrees it works. Now is the time to roll it out commercially.

  • CTV: Growing resistance to antibiotics fuels market for alternative solutions

    CTV NEWS, TORONTO – A hundred years ago, a small wound could result in death if an infection spread. That could become reality again as the world threatens to return to a pre-antibiotic era due to antibiotic resistance.

    Some have pointed to the widespread use of antibiotics in livestock feed as a culprit, resulting in urgent calls to quell their use and find alternatives.

View All Media Coverage